Synthesis, biological activity and molecular docking of new tricyclic series as α-glucosidase inhibitors
Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial glucose level. We have synthesized 25 tricyclic 2-phenoxypyrido[3...
| Published in: | BMC Chemistry |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
BioMed Central Ltd
2019
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070683368&doi=10.1186%2fs13065-019-0560-4&partnerID=40&md5=187e614587e1c2828d7c8b4148f0451a |